Supplementary Table S13 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Chuandong Geng(The University of Texas MD Anderson Cancer Center), Timothy C. Thompson(The University of Texas MD Anderson Cancer Center), Shakuntala Kondraganti(University of Illinois Urbana-Champaign), Sanghee Park(The University of Texas MD Anderson Cancer Center), Bradley M. Broom(The University of Texas MD Anderson Cancer Center), Patrick G. Pilié(The University of Texas MD Anderson Cancer Center), Christopher E. Barbieri(Cornell University), Samir Hanash(The University of Texas MD Anderson Cancer Center), Jody V. Vykoukal, Brian D. Robinson(Cornell University), Paul G. Corn(Cornell University), Timothy A. Yap(The University of Texas MD Anderson Cancer Center), Massimo Loda(Cornell University), Johannes F. Fahrmann(The University of Texas MD Anderson Cancer Center), Ganiraju C. Manyam(The University of Texas MD Anderson Cancer Center), Man-Chao Zhang(The University of Texas MD Anderson Cancer Center), Daoqi Wang(The University of Texas MD Anderson Cancer Center), Shan Peng(The University of Texas MD Anderson Cancer Center), Cheng Wu(Second Military Medical University)
Cited by 0
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
The Molecular Taxonomy of Primary Prostate Cancer
|Cell|2015|3.3k